In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Vigil Neuroscience Inc (VIGL – Research Report), with ...
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback